Roche to launch another Elevidys study, eying EU approval
Roche is launching a new global phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys…
Elevidys fallout hasn’t dented Roche’s hopes for gene therapies
The uncertainty around the future of Elevidys hasn’t destroyed Roche’s belief in the potential of gene therapies, the…
Sarepta swings to Q1 2026 profit on Roche revenue
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section…
Roche plots route to EMA approval for DMD gene therapy
To read the full story, subscribe or sign in. April 17, 2026 By Nuala Moran No Comments Roche…